Abbott Options Market Prices in 4.5% Post-Earnings Stock Move

The options market is signaling a potentially significant price swing for Abbott Laboratories (NYSE: ABT) following its upcoming quarterly earnings announcement. Traders are currently pricing in an implied move of 4.5% in either direction for the stock after the company reports on July 16, according to options data compiled by Bloomberg.

Historical Volatility

An analysis of Abbott's past earnings reports suggests that the stock has a tendency to be more volatile than the options market anticipates. The stock's actual post-earnings move has exceeded the implied move in five of the last eight quarterly announcements.

This trend of higher-than-expected volatility has been particularly pronounced in recent quarters. Notable examples include:

• April 16: The stock fell 7.8%, more than double the 3.2% implied move.
• January: Shares dropped 13.1%, significantly outpacing the 3.6% implied move.
• July 17, 2025: The stock declined 9.5% against a much smaller implied move of 2.8%.

Ad

What This Means for Investors

The implied move is derived from options prices and reflects the market's expectation of share price volatility through the earnings date. It is not a prediction of the direction of the move but rather a gauge of its potential magnitude.

For investors, this data point highlights the market's anticipation of new information that could impact the company's valuation. The historical pattern of Abbott's stock exceeding these expectations underscores the potential for a substantial reaction to the earnings results and management's forward-looking guidance, which are scheduled to be released before the market opens.